2.7M XNAS Volume
XNAS 04 Apr, 2025 5:30 PM (EDT)
| Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|
| Carrie F. Liao | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 25 Mar 2025 | 2,347 | 144,923 | - | 6.7 | 15,819 | Common Shares |
| Dan Karlin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 25 Mar 2025 | 6,836 | 446,177 | - | 6.7 | 46,075 | Common Shares |
| Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 25 Mar 2025 | 21,208 | 856,556 | - | 6.7 | 142,942 | Common Shares |
| Mark R. Sullivan | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 6.74 per share. | 25 Mar 2025 | 6,576 | 316,621 | - | 6.7 | 44,322 | Common Shares |
| Carrie F. Liao | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 50,000 | 142,270 | - | 0 | Common Shares | |
| Dan Karlin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 115,000 | 453,013 | - | 0 | Common Shares | |
| Robert B. Barrow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 350,000 | 877,764 | - | 0 | Common Shares | |
| Mark R. Sullivan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 150,000 | 323,197 | - | 0 | Common Shares | |
| Dan Karlin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 26 Dec 2024 | 6,643 | 338,013 | - | 7.4 | 49,357 | Common Shares |
| Sullivan Mark R. | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 26 Dec 2024 | 4,519 | 173,197 | - | 7.4 | 33,576 | Common Shares |
| B. Robert Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 26 Dec 2024 | 19,106 | 526,666 | - | 7.4 | 141,958 | Common Shares |
| F. Carrie Liao | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 7.43 per share. | 26 Dec 2024 | 2,273 | 97,270 | - | 7.4 | 16,888 | Common Shares |
| W. David Gryska | Director | Purchase of securities on an exchange or from another person at price $ 7.17 per share. | 05 Dec 2024 | 2,500 | 19,851 | - | 7.2 | 17,925 | Common Shares |
| Carrie F. Liao | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 25 Sep 2024 | 2,352 | 99,543 | - | 6.0 | 14,065 | Common Shares |
| Dan Karlin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 25 Sep 2024 | 6,871 | 344,656 | - | 6.0 | 41,089 | Common Shares |
| Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 25 Sep 2024 | 19,771 | 545,772 | - | 6.0 | 118,231 | Common Shares |
| Mark R. Sullivan | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 5.98 per share. | 25 Sep 2024 | 4,430 | 177,716 | - | 6.0 | 26,491 | Common Shares |
| David W. Gryska | Director | Purchase of securities on an exchange or from another person at price $ 5.98 per share. | 23 Aug 2024 | 3,500 | 17,351 | - | 6.0 | 20,930 | Common Shares |
| Miri Halperin Wernli | Executive President | 21 Aug 2024 | 32,595 | 202,405 | - | 6.2 | 201,111 | Common Shares | |
| Miri Halperin Wernli | Executive President | 21 Aug 2024 | 50,000 | 235,000 | - | 3.7 | 185,000 | Common Shares | |
| Miri Halperin Wernli | Executive President | 21 Aug 2024 | 50,000 | 0 | - | - | Stock Option (Right to Buy) | ||
| Robert B. Barrow | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.31 per share. | 19 Aug 2024 | 500 | 565,043 | - | 6.3 | 3,155 | Common Shares |
| Robert B. Barrow | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 6.12 per share. | 19 Aug 2024 | 500 | 565,543 | - | 6.1 | 3,060 | Common Shares |
| Dan Karlin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 25 Jun 2024 | 6,925 | 351,527 | - | 7.2 | 49,999 | Common Shares |
| Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 25 Jun 2024 | 15,659 | 564,543 | - | 7.2 | 113,058 | Common Shares |
| Mark R. Sullivan | Chief Legal Officer | Sale of securities on an exchange or to another person at price $ 7.22 per share. | 25 Jun 2024 | 17,854 | 182,146 | - | 7.2 | 128,906 | Common Shares |
| David W. Gryska | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 16,506 | 16,506 | - | - | Stock Option (Right to Buy) | |
| Andreas Krebs | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 16,506 | 16,506 | - | - | Stock Option (Right to Buy) | |
| Carol A. Vallone | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 16,506 | 16,506 | - | - | Stock Option (Right to Buy) | |
| Roger Crystal | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 16,506 | 16,506 | - | - | Stock Option (Right to Buy) | |
| Suzanne L. Bruhn | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2024 | 16,506 | 16,506 | - | - | Stock Option (Right to Buy) | |
| Dan Karlin | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 25 Mar 2024 | 6,578 | 358,452 | - | 9.5 | 62,491 | Common Shares |
| Robert B. Barrow | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.50 per share. | 25 Mar 2024 | 16,519 | 580,202 | - | 9.5 | 156,931 | Common Shares |
| Schond L. Greenway | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 9.78 per share. | 25 Mar 2024 | 5,560 | 211,057 | - | 9.8 | 54,377 | Common Shares |
| Carrie Liao F. | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 100,000 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Mark R. Sullivan | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Wernli Miri Halperin | Executive President | 27 Feb 2024 | 125,000 | 125,000 | - | - | Stock Option (Right to Buy) | ||
| Greenway L. Schond | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Dan Karlin | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 150,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Robert B. Barrow | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Feb 2024 | 400,000 | 400,000 | - | - | Stock Option (Right to Buy) |